 Objective To evaluate the transdiagnostic CBT in a randomized clinical trial RCT of VAMC patients with depressiveanxiety disorders by investigating its preliminary efficacy in reducing symptomatology, comorbidity, and improving quality of life compared to behavioral activation therapy BAT psychotherapy control condition. Patient satisfaction and predictors of feasibility attendance and dropout also will be assessed. 